ClinicalTrials.Veeva

Menu

Stem Cells Therapy in Advanced Heart Failure

U

University of Campania "Luigi Vanvitelli"

Status and phase

Unknown
Phase 4

Conditions

Congestive Heart Failure

Treatments

Drug: stem cells infusion

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

stem cells therapy may be a choice therapy for advanced heart failure patients refractory to medical therapy, internal cardiovertor with a defibrillator (ICD) recipients, and a previous history of myocardial infarction and coronary artery revascularization. These patients, without indication to receive a cardiac resynchronization therapy (CRT), may have a worsening of heart failure, and symptoms of coronary artery disease. In this study we have evaluated in consecutive 30 selected patients the amelioration in failing heart NYHA class, hospitalization rate, echocardiographic left ventricle functionality, and associated to reduction of angina after a treatment with stem cells intra thoracic infusion.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • heart failure post coronary artery disease, refractory to maximal medical therapy, previous coronary artery surgical revascularization.

Exclusion criteria

  • inflammatory chronic diseases, neoplastic diseases.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

stem cells infusion
Experimental group
Treatment:
Drug: stem cells infusion

Trial contacts and locations

3

Loading...

Central trial contact

Raffaele Marfella, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems